Table 2

Summary of results of eight validated somatic variants

VariantGeneFunctionSampleTissueS2NMAFCADDWES-Blood
WES-Brain
P-valuePanel-Blood
Panel-Brain
P-value
REFALTVAFREFALTVAFREFALTVAFREFALTVAF
chr1:11073909: G/ATARDBPNonsynSD14MTG9.80208700.000765100.0130.6512600.000187192710.0149 × 10−29
chr1:11073909: C/TTARDBPNonsynSD10DGNA02813800.000103700.0001934940.00075331520.0203 × 10−47
chr9:130928555: T/GCIZ1NonsynSD11DG20.80163900.000323540.1430.00513400.000346350.0923 × 10−5
chr17:4883215: A/GCAMTA2NonsynSD09DG11.10185810.017420420.0910.0714610.0071058240.0220.4
chr17:34192311: T/GHEATR9NonsynSD11DG7.60137200.000278210.0700.023232240.007180313290.0183 × 10−6
chr17:70119726: C/ASOX9NonsynSD14DG9.00205610.018405150.0360.7167650.0031133760.0639 × 10−24
chr19:51133405: A/GSYT3NonsynSD11DG8.50141400.000227250.0990.410300.0001593290.0180.4
chr19:51133405: A/GSYT3NonsynSD09DG12.40142100.000236400.1450.0928910.0031829290.0160.2
VariantGeneFunctionSampleTissueS2NMAFCADDWES-Blood
WES-Brain
P-valuePanel-Blood
Panel-Brain
P-value
REFALTVAFREFALTVAFREFALTVAFREFALTVAF
chr1:11073909: G/ATARDBPNonsynSD14MTG9.80208700.000765100.0130.6512600.000187192710.0149 × 10−29
chr1:11073909: C/TTARDBPNonsynSD10DGNA02813800.000103700.0001934940.00075331520.0203 × 10−47
chr9:130928555: T/GCIZ1NonsynSD11DG20.80163900.000323540.1430.00513400.000346350.0923 × 10−5
chr17:4883215: A/GCAMTA2NonsynSD09DG11.10185810.017420420.0910.0714610.0071058240.0220.4
chr17:34192311: T/GHEATR9NonsynSD11DG7.60137200.000278210.0700.023232240.007180313290.0183 × 10−6
chr17:70119726: C/ASOX9NonsynSD14DG9.00205610.018405150.0360.7167650.0031133760.0639 × 10−24
chr19:51133405: A/GSYT3NonsynSD11DG8.50141400.000227250.0990.410300.0001593290.0180.4
chr19:51133405: A/GSYT3NonsynSD09DG12.40142100.000236400.1450.0928910.0031829290.0160.2

All eight variants passed the validation criteria. WES-Blood/WES-Brain shows the read counts for variant and wild-type from exome sequencing. Panel-Blood/Panel-Brain shows the counts for the amplicon panel. ALT = number of reads carrying the alternative allele; MAF = minor allele frequency; Nonsyn = non-synonymous; REF = number of reads carrying the reference allele; S2N = signal to noise; VAF = variant allele frequency. P-values were obtained by Fisher’s exact tests of the counts between blood and brain.

Table 2

Summary of results of eight validated somatic variants

VariantGeneFunctionSampleTissueS2NMAFCADDWES-Blood
WES-Brain
P-valuePanel-Blood
Panel-Brain
P-value
REFALTVAFREFALTVAFREFALTVAFREFALTVAF
chr1:11073909: G/ATARDBPNonsynSD14MTG9.80208700.000765100.0130.6512600.000187192710.0149 × 10−29
chr1:11073909: C/TTARDBPNonsynSD10DGNA02813800.000103700.0001934940.00075331520.0203 × 10−47
chr9:130928555: T/GCIZ1NonsynSD11DG20.80163900.000323540.1430.00513400.000346350.0923 × 10−5
chr17:4883215: A/GCAMTA2NonsynSD09DG11.10185810.017420420.0910.0714610.0071058240.0220.4
chr17:34192311: T/GHEATR9NonsynSD11DG7.60137200.000278210.0700.023232240.007180313290.0183 × 10−6
chr17:70119726: C/ASOX9NonsynSD14DG9.00205610.018405150.0360.7167650.0031133760.0639 × 10−24
chr19:51133405: A/GSYT3NonsynSD11DG8.50141400.000227250.0990.410300.0001593290.0180.4
chr19:51133405: A/GSYT3NonsynSD09DG12.40142100.000236400.1450.0928910.0031829290.0160.2
VariantGeneFunctionSampleTissueS2NMAFCADDWES-Blood
WES-Brain
P-valuePanel-Blood
Panel-Brain
P-value
REFALTVAFREFALTVAFREFALTVAFREFALTVAF
chr1:11073909: G/ATARDBPNonsynSD14MTG9.80208700.000765100.0130.6512600.000187192710.0149 × 10−29
chr1:11073909: C/TTARDBPNonsynSD10DGNA02813800.000103700.0001934940.00075331520.0203 × 10−47
chr9:130928555: T/GCIZ1NonsynSD11DG20.80163900.000323540.1430.00513400.000346350.0923 × 10−5
chr17:4883215: A/GCAMTA2NonsynSD09DG11.10185810.017420420.0910.0714610.0071058240.0220.4
chr17:34192311: T/GHEATR9NonsynSD11DG7.60137200.000278210.0700.023232240.007180313290.0183 × 10−6
chr17:70119726: C/ASOX9NonsynSD14DG9.00205610.018405150.0360.7167650.0031133760.0639 × 10−24
chr19:51133405: A/GSYT3NonsynSD11DG8.50141400.000227250.0990.410300.0001593290.0180.4
chr19:51133405: A/GSYT3NonsynSD09DG12.40142100.000236400.1450.0928910.0031829290.0160.2

All eight variants passed the validation criteria. WES-Blood/WES-Brain shows the read counts for variant and wild-type from exome sequencing. Panel-Blood/Panel-Brain shows the counts for the amplicon panel. ALT = number of reads carrying the alternative allele; MAF = minor allele frequency; Nonsyn = non-synonymous; REF = number of reads carrying the reference allele; S2N = signal to noise; VAF = variant allele frequency. P-values were obtained by Fisher’s exact tests of the counts between blood and brain.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close